112 related articles for article (PubMed ID: 8106287)
41. [Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
Fujita F; Fujita M; Inaba H; Taguchi T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):223-8. PubMed ID: 8434959
[TBL] [Abstract][Full Text] [Related]
42. Glycosaminoglycans in human lung carcinoma.
Hatae Y; Atsuta T; Makita A
Gan; 1977 Feb; 68(1):59-63. PubMed ID: 863174
[TBL] [Abstract][Full Text] [Related]
43. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
44. [Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].
Shirasaka T; Fujita F; Fujita M; Fukushima M; Taguchi T; Fujii S
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1871-6. PubMed ID: 2393305
[TBL] [Abstract][Full Text] [Related]
45. Selenium level and glutathione-dependent enzyme activities in normal and neoplastic human lung tissues.
Di Ilio C; Del Boccio G; Casaccia R; Aceto A; Di Giacomo F; Federici G
Carcinogenesis; 1987 Feb; 8(2):281-4. PubMed ID: 3802412
[TBL] [Abstract][Full Text] [Related]
46. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
Ueda M; Misaki O; Yamada T; Okamoto Y; Goto M; Maeda T; Okamura S; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
[TBL] [Abstract][Full Text] [Related]
47. Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.
Nakamura T; Shinriki S; Jono H; Ueda M; Nagata M; Guo J; Hayashi M; Yoshida R; Ota T; Ota K; Kawahara K; Nakagawa Y; Yamashita S; Nakayama H; Hiraki A; Shinohara M; Ando Y
FEBS Lett; 2015 Jan; 589(2):231-9. PubMed ID: 25497015
[TBL] [Abstract][Full Text] [Related]
48. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
[TBL] [Abstract][Full Text] [Related]
49. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.
Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K
Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493
[TBL] [Abstract][Full Text] [Related]
50. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
Chen P; Yu J; Knecht J; Chen Q
Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
[TBL] [Abstract][Full Text] [Related]
51. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
52. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
53. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
54. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T
BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of bone morphogenetic protein 5 in human lung squamous cell carcinoma and adenocarcinoma.
Deng T; Lin D; Zhang M; Zhao Q; Li W; Zhong B; Deng Y; Fu X
Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):557-63. PubMed ID: 25994008
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary haptoglobin: a new marker for adenocarcinomas of the lung?
Abdullah M; Marwitz S; Kähler D; Schultz H; Kugler C; Zabel P; Vollmer E; Goldmann T
Pathology; 2011 Jan; 43(1):70-2. PubMed ID: 21240070
[No Abstract] [Full Text] [Related]
57. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
58. Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.
Suzuki S; Hongu Y; Fukazawa H; Ichihara S; Shimizu H
Gan; 1980 Apr; 71(2):238-45. PubMed ID: 6451469
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
